Selank 10mg Pen

Price range: Rp1,600,000.00 through Rp2,200,000.00 ~$96.97–$133.33

Selank 10mg Pen is a convenient, ready-to-use peptide commonly associated with calm focus, mood support, and mental clarity.
No mixing required — simple and easy to use.

✔ No mixing required
✔ Easy-to-use pen
✔ Calm focus support
✔ Fast Bali delivery

10 Needles + 10 Alcohol pads included.
Description

Selank 10 mg Pen

Product Description

Selank is a synthetic regulatory heptapeptide derived from research into tuftsin, an endogenous immunomodulatory peptide. It is primarily investigated in the areas of stress-response biology, anxiety-related behaviour, neurotransmitter regulation, neuroimmune signalling, and cognitive performance.

Unlike classical benzodiazepines, Selank is not described as a direct GABA-A receptor agonist. Instead, experimental research suggests that it may influence GABAergic tone, serotonin and dopamine metabolism, neurotrophic signalling, and stress-related gene expression through regulatory mechanisms. Pasted text

The Atlas Longevity Selank pen contains 10 mg in a 3 mL cartridge with 300 total units/clicks.

Selank remains an investigational neuropeptide. Human research exists, but it is limited and regionally concentrated, so Selank should not be presented as an approved treatment for anxiety disorders, depression, cognitive impairment, stress, or other neurological conditions.


Clinical / Research Status

The supplied material describes Selank as being studied primarily in neurobehavioral and anxiolytic research, with limited human clinical investigation alongside more extensive animal and laboratory research. Pasted text

Evidence Type Status Based on Supplied Material
Human controlled research Limited / regional
Human observational research Limited
Animal research Yes
In-vitro research Yes
Regulatory therapeutic approval Not established

Human findings should therefore be described as exploratory rather than definitive clinical evidence.


Evidence Type

The supplied material references research involving:

  • anxiety-related clinical studies;
  • rodent elevated plus-maze models;
  • cortical neurotransmitter analysis;
  • hippocampal BDNF research;
  • stress-induced immune models;
  • cognitive performance studies;
  • enkephalin-degradation assays. Pasted text

This evidence spans human, animal, and cellular research, with different levels of relevance to real-world therapeutic outcomes.


Mechanism of Action

Selank is studied primarily as a regulatory neuropeptide rather than a classical direct receptor agonist.

The supplied material describes several potential mechanisms:

  • modulation of GABA turnover;
  • regulation of inhibitory neurotransmission;
  • effects on serotonin pathways;
  • effects on dopamine metabolism;
  • changes in inflammatory cytokine expression;
  • modulation of neurotrophic factors;
  • stress-response signalling. Pasted text

GABAergic Regulation

Selank is not described as binding directly to GABA-A receptors in the same way as benzodiazepines.

Instead, experimental studies suggest that it may influence the regulation and turnover of GABA-related signalling.

Monoamine Signalling

Research also describes changes involving serotonin and dopamine metabolism, particularly under experimental stress conditions.

Neuroimmune Signalling

Gene-expression studies referenced by the source suggest potential effects on inflammatory and neurotrophic pathways, creating interest in the interaction between immune signalling and brain function.

These mechanisms remain under investigation and should not be presented as established therapeutic effects in humans.


Potential Benefits / Research Areas

GABAergic Signalling Research

One of the central research areas for Selank is its possible influence on GABA-related inhibitory signalling.

Animal and limited human research have investigated whether Selank can modify GABA turnover without producing the same direct receptor activation associated with benzodiazepines. Pasted text

The supplied material describes reduced anxiety-related measures with less pronounced motor impairment in experimental settings.

This does not establish Selank as an approved anxiolytic medicine.

Serotonin and Dopamine Research

Selank has also been investigated for potential effects on monoamine neurotransmission.

The supplied source discusses changes in serotonin and dopamine metabolism, transporter expression, and receptor-related signalling under stress conditions. Pasted text

These findings remain primarily mechanistic and exploratory.

Anxiety-Related Research

Limited clinical research has examined Selank in populations with anxiety-related symptoms.

The supplied material describes reductions in anxiety scoring measures and preservation of attention or cognition in some studies. Pasted text

The evidence is not sufficient to describe Selank as a universally established treatment for anxiety disorders.

Stress-Response Biology

Animal research has investigated Selank’s potential influence on the hypothalamic-pituitary-adrenal (HPA) axis and stress-related corticosterone responses. Pasted text

This makes Selank relevant to research examining the interaction between stress hormones, neurotransmitters, and behavioural responses.

Neuroimmune Research

The supplied source describes gene-expression changes involving inflammatory cytokines and neuroimmune pathways.

This has created research interest in possible connections among:

  • neural signalling;
  • inflammation;
  • immune regulation;
  • stress responses. Pasted text

These findings should not be interpreted as proof that Selank treats inflammatory or immune disease.

Cognitive Performance Under Stress

Experimental research has examined Selank in memory, attention, and executive-function tasks conducted under stress.

The source reports preservation or improvement of certain cognitive measures in selected models. Pasted text

This does not establish Selank as a clinically proven cognitive enhancer.

Non-Sedative Anxiolytic Research

An important research characteristic of Selank is its reported lack of pronounced sedation in certain models.

The supplied source describes relatively preserved motor coordination and reaction time compared with more strongly sedating anxiolytic compounds. Pasted text

This remains a research observation rather than a guarantee of no sedation or impairment.

Neuroplasticity Research

The source also references changes in BDNF-related expression, which has generated interest in Selank’s potential effects on neuroplasticity and neuronal adaptation. Pasted text

Most of this evidence is preclinical.


Research Data

Study / Model Reported Finding
Anxiety-related clinical research Reduced anxiety scores with less sedation reported in selected studies
Rat elevated plus-maze Reduced anxiety-like behaviour and increased open-arm exploration
Rodent cortical neurotransmitter analysis Changes in GABA turnover and serotonin/dopamine metabolism
Hippocampal BDNF studies Increased BDNF-related gene expression
Stress-induced immunosuppression models Changes in interferon and cytokine balance
Cognitive-performance research Changes in attention, memory and mental-performance measures
Enkephalin degradation assays Reduced enkephalin breakdown in experimental systems

These findings come from different research models and should not all be interpreted as established human clinical benefits. Pasted text


Potential Stack / Combination Research

The supplied source discusses experimental combinations involving Selank with:

  • Semax;
  • BPC-157;
  • Cerebrolysin;
  • NAD+. Pasted text

The proposed research rationale involves combining stress-response, neurotrophic, regenerative, or cellular-energy pathways.

However, the supplied information does not establish validated human safety, compatibility, efficacy, or dosing for these combinations.

They should therefore be treated as experimental research concepts rather than recommended stacks.


Atlas Longevity Selank Pen Dosage / Click Chart

The Atlas Longevity Selank pen contains:

10 mg Selank

3 mL cartridge volume

300 total clicks

1 click = 0.01 mL

Maximum selectable dial amount = 60 clicks

Pen Specification

Pen Strength Volume Concentration Amount Per Click
10 mg 3 mL ≈3.333 mg/mL ≈0.0333 mg / 33.3 mcg

Concentration Calculation

10 mg ÷ 3 mL = 3.3333 mg/mL

Rounded:

≈3.333 mg/mL

Amount Per Click

10 mg ÷ 300 clicks = 0.033333 mg per click

Therefore:

1 click ≈0.0333 mg

or:

≈33.3 mcg Selank


Selank Click Conversion Chart

Clicks Volume Selank Amount
1 0.01 mL ≈0.0333 mg / 33.3 mcg
3 0.03 mL 0.100 mg / 100 mcg
5 0.05 mL ≈0.1667 mg
6 0.06 mL 0.200 mg
9 0.09 mL 0.300 mg
10 0.10 mL ≈0.333 mg
15 0.15 mL 0.500 mg
20 0.20 mL ≈0.667 mg
27 0.27 mL 0.900 mg
30 0.30 mL 1.000 mg
40 0.40 mL ≈1.333 mg
45 0.45 mL 1.500 mg
60 0.60 mL 2.000 mg

Useful Conversions

  • 3 clicks = 0.10 mg
  • 6 clicks = 0.20 mg
  • 9 clicks = 0.30 mg
  • 15 clicks = 0.50 mg
  • 27 clicks = 0.90 mg
  • 30 clicks = 1 mg
  • 60 clicks = 2 mg

The maximum selectable amount in one dial operation is:

60 clicks = 0.60 mL = 2 mg Selank

This is a mathematical concentration conversion and not a dosing recommendation.


Protocol / Dosage Information

The supplied source describes experimental quantities ranging from approximately 0.10 mg to 0.90 mg in several proposed research protocols. Pasted text

Its original click calculations were based on a different 10 mg / 2 mL formulation, so those click values should not be used for the Atlas Longevity 3 mL pen.

Using the Atlas 10 mg / 3 mL / 300-click formulation:

Source-Referenced Amount Atlas Pen Mathematical Equivalent
0.10 mg 3 clicks
0.20 mg 6 clicks
0.25 mg ≈7.5 clicks*
0.30 mg 9 clicks
0.50 mg 15 clicks
0.90 mg 27 clicks

*A calculated value of 7.5 clicks cannot be selected exactly using whole pen units.

The source also provides duration, frequency, cycling, and combination schedules. Those should not be reproduced as self-administration instructions for the Atlas product.

The table above simply translates source-referenced quantities into Atlas concentration mathematics.


Possible Side Effects

The supplied material describes Selank as generally well tolerated in animal and limited human research, but the available evidence is not sufficient to establish a complete long-term safety profile.

Reported observations include:

  • mild drowsiness;
  • temporary fatigue;
  • headache;
  • light-headedness;
  • localized redness;
  • injection-site irritation. Pasted text

The source also mentions nasal discomfort associated with intranasal research, which should not automatically be applied to an Atlas pen formulation.

Sedation and Cognitive Effects

The source reports less pronounced sedation or cognitive impairment than classical anxiolytic compounds in available research.

However, this should not be interpreted as proof that Selank can never cause drowsiness, reduced alertness, or cognitive effects.

Dependence and Withdrawal

The supplied source states that dependence and withdrawal have not been observed in the available research data.

Because human studies are limited, absence of a signal should not be interpreted as proof of zero dependence or withdrawal risk under every exposure pattern.

Important areas of uncertainty include:

  • long-term repeated systemic exposure;
  • psychiatric medication interactions;
  • other CNS-active compounds;
  • pregnancy and reproductive exposure;
  • neurological disorders;
  • chronic psychiatric conditions;
  • combination protocols.

Product Attributes

Attribute Information
Compound Name Selank
CAS Number 129954-34-3
Molecular Formula C33H57N11O9
Amino Acid Sequence TKPRPGP-NH2
Peptide Length 7 amino acids
Molecular Weight 751.88 g/mol
PubChem CID 11765600
Half-Life listed by source Approximately 30 minutes for intranasal administration; central activity may persist longer
Synonyms TP-7, Tuftsin analogue, Threonyl-Lysyl-Prolyl-Arginyl-Prolyl-Glycyl-Proline amide
Compound Type Synthetic regulatory heptapeptide
Research Focus Stress-response biology, anxiety-related research, cognition and neuroimmune signalling

These specifications are reported in the supplied reference material.

Included in the Box

Each Atlas Longevity product is carefully packed to support secure storage, clean handling, and convenient research use. Inside the package, you’ll find the essential items needed for organized laboratory handling:

  • 1× Ready-to-Use Injection Pen
  • 10× Ultra-Fine Needles (33G, 4 mm)
  • 10× Alcohol Prep Pads
  • Protective Foam Insert to help keep the pen secure during transport
  • Quick-Reference Instruction Panel inside the packaging
  • Tamper-Evident Security Seal for added package protection

Each component is arranged in a clean, protective presentation designed to keep the product secure and easy to access.

Storage

Storage conditions should follow the instructions supplied specifically with the Atlas Longevity Selank formulation.

The reference product provides refrigeration and stability specifications for its own finished formulation. Those conditions should not automatically be transferred to Atlas Longevity without formulation-specific stability evidence.

Follow the temperature requirements, light-protection guidance, handling instructions, and shelf-life information printed on the Atlas Longevity product label or accompanying documentation.

The half-life cited by the source specifically references intranasal administration. It should not automatically be presented as the established pharmacokinetic half-life of an Atlas subcutaneous formulation.

 


Frequently Asked Questions

What is Selank?

Selank is a synthetic seven-amino-acid regulatory peptide derived from tuftsin-related research.

It is primarily investigated for potential effects involving stress responses, GABAergic signalling, monoamine regulation, cognition, and neuroimmune pathways. Pasted text

Is Selank a benzodiazepine?

No.

Selank is a peptide and is not a benzodiazepine.

The supplied research specifically distinguishes its mechanism from direct GABA-A receptor agonism.

How does Selank work?

Selank is studied for potential regulatory effects on:

  • GABA turnover;
  • serotonin metabolism;
  • dopamine signalling;
  • inflammatory gene expression;
  • BDNF-related pathways;
  • stress-response systems. Pasted text

Its exact clinical significance in humans remains under investigation.

Does Selank directly activate GABA receptors?

The supplied source states that Selank does not directly bind GABA-A receptors in the same way as classical benzodiazepine compounds.

Instead, it is researched for its ability to influence GABAergic regulation indirectly. Pasted text

What is Selank researched for?

Research areas include:

  • anxiety-related behaviour;
  • stress response;
  • GABA signalling;
  • serotonin and dopamine regulation;
  • neuroimmune signalling;
  • BDNF expression;
  • attention and memory;
  • cognitive performance under stress.

Human evidence remains limited.

Has Selank been studied in humans?

Yes.

The supplied material references limited clinical research, including anxiety-related studies and comparative research involving medazepam. Pasted text

However, the human evidence base is much smaller than that of established anxiolytic medicines.

Is Selank approved for anxiety?

The supplied material does not establish broad regulatory approval of Selank as a treatment for anxiety disorders.

Its use should therefore remain framed as investigational research.

Does Selank cause sedation?

The supplied source describes relatively little sedation in available studies compared with classical anxiolytic compounds.

However, mild drowsiness and fatigue are also listed among reported observations. Pasted text

Therefore, describing Selank as completely non-sedating would be too strong.

Is Selank addictive?

The supplied source reports no observed dependence or withdrawal in the research it references.

The limited size of the human evidence base means this should not be interpreted as definitive proof of zero dependence potential.

Is Selank researched for cognition?

Yes.

Experimental studies described by the source have investigated attention, memory, cognitive stability, and performance under stress.

These findings do not establish Selank as an approved cognitive enhancer.

What is BDNF and why is it relevant to Selank research?

BDNF — brain-derived neurotrophic factor — is involved in neuronal survival, adaptation, and neuroplasticity.

The supplied source references experimental research reporting changes in BDNF-related expression following Selank exposure. Pasted text

How much Selank is in each Atlas Longevity pen?

Each Atlas Longevity Selank pen contains:

10 mg Selank in 3 mL.

What is the concentration of the Selank pen?

The concentration is:

10 mg ÷ 3 mL = approximately 3.333 mg/mL

How many clicks are in the Selank pen?

Each pen contains:

300 total clicks / units

with:

1 click = 0.01 mL

How much Selank is in one click?

Each click contains approximately:

0.0333 mg

or:

33.3 mcg Selank

How many clicks equal 0.1 mg?

3 clicks = 0.10 mg.

How many clicks equal 0.2 mg?

6 clicks = 0.20 mg.

How many clicks equal 0.3 mg?

9 clicks = 0.30 mg.

How many clicks equal 0.5 mg?

15 clicks = 0.50 mg.

How many clicks equal 0.9 mg?

27 clicks = 0.90 mg.

These are concentration calculations rather than dosing recommendations.

What is the maximum selectable amount on the Selank pen?

The maximum single dial selection is:

60 clicks

which equals:

0.60 mL

and:

2 mg Selank

This describes the mechanical range of the pen rather than a recommended amount.

How long does a Selank pen last?

The complete pen contains:

300 clicks and 10 mg Selank.

The number of administrations depends on the number of clicks selected each time.

For cartridge-capacity calculations only:

  • 3 clicks at a time = 100 administrations
  • 6 clicks at a time = 50 administrations
  • 10 clicks at a time = 30 administrations
  • 15 clicks at a time = 20 administrations
  • 30 clicks at a time = 10 administrations
  • 60 clicks at a time = 5 administrations

These examples describe pen capacity rather than a treatment protocol.

Does the product disappear when the dial returns to zero?

No.

After administration, the dial returns to zero while the unused formulation remains inside the cartridge.

The remaining Selank stays in the pen until all 300 units have been used.

Can Selank be combined with Semax?

The supplied source discusses Selank + Semax as an experimental research combination involving stress-related and cognitive pathways. Pasted text

Validated human combination safety, efficacy, compatibility, and dosing are not established by the supplied material.

Can Selank be combined with NAD+?

The source also discusses Selank + NAD+ as an experimental concept involving neurotransmitter regulation and neuronal energy metabolism.

This remains a research concept rather than an established clinical combination.

Is there an established human dosage for the Atlas Selank pen?

The supplied source provides experimental quantities, but these were based on a different formulation and do not establish a universally accepted therapeutic dose for the Atlas pen.

The Atlas click chart therefore represents concentration mathematics only.

How should the Atlas Longevity Selank pen be stored?

Follow the storage instructions supplied specifically with the actual Atlas Longevity formulation.

The reference manufacturer’s refrigeration and stability claims apply to its own finished product and should not automatically be transferred to Atlas without formulation-specific stability evidence.